信达生物盈利;北京将新设100亿元规模医药并购基金

Ofweek光电信息网
27 Mar

信达生物率先盈利。3月26日,信达生物发布2024年财报。报告期内,公司收入94.21亿元,同比增长51.8%;成功扭亏为盈,净利润为3.3亿元。北京再设医药并购基金。3月26日,北京市医保局局长马继业3月26日在博鳌亚洲论坛期间的一场活动中表示,北京市充分发挥市级200亿元医药健康投资基金的作用,2024年,投决金额和撬动社会资本近100亿元。今年将再新设100亿元规模的医药并购基金,构建全周期...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10